SARS-CoV-2 (Covid-19), Respiratory Disease, Inflammatory Marker, etc
SARS-CoV-2 (Covid-19), Respiratory Disease, Cardiac Marker, etc
SARS-CoV-2 (Covid-19), Respiratory Disease, Inflammatory Marker, etc
Inflammatory Marker, Cardiac Marker, etc
Polymerase, Taq Polymerase, Taq Antibody, Modified Taq with Antibody, etc
Cnpair Biotech Co., Ltd. is dedicated to balance of specificity and sensitivity! Considering the performance of final test kits, Cnpair always gives priority to Specificity, Sensitivity and Stability in the whole development of immunoassay materials (Antibodies and Antigen), especially for development of antibody to Nucleocapsid Protein (N protein) of SARS-CoV-2 virus. Those Covid-19 antigen rapid test with core materials (antibodies) from Cnpair have perfected overall performance, and both sensitivity and specificity meet requirements. By doing so, Cnpair is supporting Covid-19 antigen rapid test manufacturers to provide huge volume of kits to patients, institutes and government, in order to improve public health in the
Nucleic acid detection reagent (Anti-Taq DNA Polymerase Antibody) Cat. # Product description Suggestion P1036 Anti-Taq Antibody Broad-spectrum recognition, excellent inhibitory efficiency Hot start PCR
The COVID-19 caused by the new coronavirus (2019-nCoV) draws everyone's attention. The diagnosis of new coronavirus infection is an important part of the epidemic prevention and control. As a professional supplier of raw materials for in vitro diagnostic reagents, Cnpair always pays close attention to the development of the epidemic. After in-depth analysis of viral gene sequences and construction of specific protein sequences, Cnpair successfully developed a series of recombinant proteins for serological detection of 2019-nCoV. At present, Cnpair has successfully developed the COVID-19 (2019-nCoV) Nucleocapsid protein (N-protein) and (2019-nCoV) Spike protein (S-protein) recombinant proteins. Both proteins meet the needs of 2019-nCoV detection
